Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 5Phase NA 3Phase EARLY_PHASE1 3Phase 1/2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2

Conditions

Breast Neoplasms 2Bone Diseases 1Biomarker Change Linked to Breast Cancer 1

Interventions

Trastuzumab 72Paclitaxel 63Cyclophosphamide 56pembrolizumab 52Fulvestrant 42Carboplatin 39Capecitabine 37Docetaxel 32Letrozole 27Doxorubicin 23palbociclib 21pertuzumab 20Nivolumab 18eribulin 17abemaciclib 17ribociclib 16Gemcitabine 16130-nm albumin-bound paclitaxel 16durvalumab 15Everolimus 15Albumin-Bound Paclitaxel 15sacituzumab govitecan 14Lapatinib 14Filgrastim 14fludarabine 13exemestane 13Taxes 13Bevacizumab 13Cisplatin 12olaparib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Vitamin D × Breast × Clear all
NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
45 enrolled
Breast

Breast Neoplasms

NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
31 enrolled
Breast

Biomarker Change Linked to Breast Cancer

NCT00904423 2017-02-14

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Stanford University

Phase 1/2 Terminated
8 enrolled 4 charts
Breast

Bone Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡